Human trials for Covid-19 vaccine may begin in 6 months: ICMR Official
As
India ranked 10th in the global infection list, overtaking Iran, which was an
early hotspot of coronavirus,
India's top medical body has said the human trials of Covid-19 vaccine may begin at least in six months.
Speaking
to IANS, Dr. Rajni Kant, Director Regional Medical Research Centre and Head at
the Indian Council of Medical Research (ICMR) said, "The virus strain
isolated at the National Institute of Virology (NIV) laboratory in Pune will be
used to develop the vaccine, and this strain has been successfully transferred
to the Bharat Biotech International Ltd. (BBIL). It is expected that the human
trials of the vaccine will begin in at least six months."
Queried
on the focus areas as India inches closer to 140,000 Covid-19 cases, Kant said
we should not get anxious about the rapid increase in numbers, especially in
the past week, which saw 5,000 Covid-19 cases daily, instead focus on
protecting the most vulnerable group. Read More
Comments
Post a Comment